Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of General Virology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/VIR.0.80530-0PMID 15604448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein.

  2004cited by this paper
• Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

  2004cited by this paper
• Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral Nucleocapsid

  2004cited by this paper
• The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain

  2004cited by this paper
• Antibody detection of SARS-CoV spike and nucleocapsid protein

  2004cited by this paper
• Analysis of multimerization of the SARS coronavirus nucleocapsid protein

  2004cited by this paper
• Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

  2004cited by this paper
• Severe Acute Respiratory Syndrome

  2004cited by this paper
• Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus

  2004cited by this paper
• The Severe Acute Respiratory Syndrome

  2003cited by this paper
• Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

  2003cited by this paper
• The Genome Sequence of the SARS-Associated Coronavirus

  2003cited by this paper
• Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

  2003cited by this paper
• Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein

  2003cited by this paper
• Effects of a SARS-associated coronavirus vaccine in monkeys

  2003cited by this paper
• Nucleocapsid-Independent Specific Viral RNA Packaging via Viral Envelope Protein and Viral RNA Signal

  2003cited by this paper
• Genetic Evidence for a Structural Interaction between the Carboxy Termini of the Membrane and Nucleocapsid Proteins of Mouse Hepatitis Virus

  2002cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus.

  2001cited by this paper
• Development of a preventive vaccine for Ebola virus infection in primates

  2000cited by this paper
• The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection

  1997cited by this paper
• Endosomal association of a protein phosphatase with high dephosphorylating activity against a coronavirus nucleocapsid protein

  1991cited by this paper
• In vivo and in vitro models of demyelinating disease. Possible relationship between induction of regulatory subunit from cAMP dependent protein kinases and inhibition of JHMV replication in cultured oligodendrocytes.

  1990cited by this paper
• Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein

  1990cited by this paper
• In Vivo and in Vitro Models of Demyelinating Disease

  1987cited by this paper
• Phosphorylation of the mouse hepatitis virus nucleocapsid protein

  1986cited by this paper
• Bovine coronavirus structural proteins

  1982cited by this paper
• Polypeptides of infectious bronchitis virus. I. Polypeptides of the virion.

  1981cited by this paper
• Phosphoproteins of murine hepatitis viruses

  1979cited by this paper

• Advances in adenovirus-based coronavirus vaccines

  2025cites this paper
• Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform

  2024cites this paper
• Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform

  2023cites this paper
• A conserved N protein nano‐vaccine of COVID‐19 exerts potent and cross‐reactive humoral and cellular immune responses in mice

  2023cites this paper
• The COVID-19 Pandemic and Relevant Concerns for Pediatric Neurologists

  2022cites this paper
• Genetics and Molecular Biology

  2022cites this paper
• Time Course Evaluation of Enzyme-Linked Immunosorbent Assays Based on Cell-Free Recombinant Proteins for Detection of Antibodies against Middle East Respiratory Syndrome Coronavirus

  2022cites this paper
• Contemporary Enzyme-Based Methods for Recombinant Proteins In Vitro Phosphorylation

  2021cites this paper
• Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies

  2021cites this paper
• The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play International Journal of Biological Macromolecules

  2021cites this paper
• COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development

  2021cites this paper
• The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play

  2021cites this paper
• Neuropathies and neurological dysfunction induced by coronaviruses

  2021cites this paper
• Coronavirus Infections in Children Including COVID-19

  2020cites this paper
• Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic

  2020cites this paper
• The Novel Coronavirus 2019 (COVID-19): A Narrative Review

  2020cites this paper
• SARS-CoV-2 Potential Therapeutic and Immunologic Targets-A Review

  2020cites this paper
• SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle

  2020cites this paper
• SARS-CoV-2 Nucleocapsid protein is decorated with multiple N- and O-glycans

  2020cites this paper
• SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes

  2020cites this paper
• : Machine Learning Maps Research Needs in COVID-19 Literature

  2020cites this paper
• Machine Learning Maps Research Needs in COVID-19 Literature

  2020cites this paper
• Vaccination strategies to combat novel corona virus SARS-CoV-2

  2020cites this paper
• Pain Management Under COVID-19

  2020cites this paper
• Coronavirus Infections in Children Including COVID-19 An Overview of the Epidemiology , Clinical Features , Diagnosis , Treatment and Prevention Options in Children

  2020cites this paper
• Nanowire Field-Effect Transistor Biosensors

  2017cites this paper
• Induction of PrPSc-specific systemic and mucosal immune responses in white-tailed deer with an oral vaccine for chronic wasting disease

  2017cites this paper
• Regulation of IRF-3-Dependent Innate Immune Signaling Pathway by the PLpro Domain of Non-Structural Protein 3 (NSP3) of Severe Acute Respiratory Syndrome (SARS) Coronavirus

  2016cites this paper
• Phosphorylation of the viral coat protein regulates RNA virus infection

  2016cites this paper
• Infectious Bronchitis in Poultry: Constraints and Biotechnological Developments in Vaccines

  2015cites this paper
• Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion

  2015cites this paper
• TheWoodchuck as a Preclinical Model for Pathogenesis and Therapy of Chronic Hepatitis

  2014cites this paper
• HOW PREPARED ARE WE TO CONTROL SEVERE ACUTE RESPIRATORY SYNDROME IN FUTURE

  2013cites this paper
• Production of cytokines in human whole blood after incubation with the nucleocapsid protein of the NL63 Coronavirus

  2012cites this paper
• DNA Prime-Adenovirus Boost Immunization Induces a Vigorous and Multifunctional T-Cell Response against Hepadnaviral Proteins in the Mouse and Woodchuck Model

  2012cites this paper
• EXPRESSION OF HUMAN CORONAVIRUS NL63 AND SARS-CoV NUCLEOCAPSID PROTEINS FOR ANTIBODY PRODUCTION

  2012cites this paper
• Improvement of therapeutic vaccination for the treatment of chronic hepatitis B in a preclinical model (woodchuck)

  2011influential citation
• Identification and characterization of a neutralizing-epitope-containing spike protein fragment in turkey coronavirus

  2011cites this paper
• Cloning and expression of human cyclophilin A and its interaction with human coronavirus NL63 nucleocapsid protein

  2011cites this paper
• Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck

  2010cites this paper
• Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A*2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein

  2010cites this paper
• DEVELOPMENT OF NOVEL VACCINE CANDIDATES FOR MEASLES

  2010cites this paper
• SARS coronavirus protein 7a interacts with

  2010cites this paper
• Molecular biology of the SARS-coronavirus

  2010cites this paper
• Molecular characterization of 52K protein of bovine adenovirus type 3

  2010cites this paper
• SARS coronavirus protein 7a interacts with human Ap4A-hydrolase

  2010cites this paper
• [Recent developments in SARS vaccine studies].

  2010cites this paper
• Mucosal adenovirus-vectored vaccine for measles.

  2010cites this paper
• A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model

  2010cites this paper
• Complete Nucleotide Analysis of the Structural Genome of the Infectious Bronchitis Virus Strain Md27 Reveals its Mosaic Nature

  2009cites this paper
• The Nucleocapsid Protein of the SARS Coronavirus: Structure, Function and Therapeutic Potential

  2009cites this paper
• Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes.

  2009cites this paper
• SARS vaccines: where are we?

  2009cites this paper
• A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus

  2008cites this paper
• Development of subunit vaccines against severe acute respiratory syndrome.

  2008cites this paper
• Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses

  2008cites this paper
• The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation

  2008cites this paper
• Complete genomic sequence of turkey coronavirus

  2008cites this paper
• Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease

  2007cites this paper
• Antigenic characterization of severe acute respiratory syndrome-coronavirus nucleocapsid protein expressed in insect cells: The effect of phosphorylation on immunoreactivity and specificity

  2007cites this paper
• The SARS-CoV nucleocapsid protein: A protein with multifarious activities

  2007cites this paper
• Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections

  2006cites this paper
• Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs

  2006cites this paper
• The Molecular Biology of Coronaviruses

  2006cites this paper
• A POTENTIAL TARGET FOR ANTIVIRAL

  2006cites this paper
• O.018 Therapeutic vaccination in chronic hepatitis B: pre-clinical studies in the woodchuck

  2006cites this paper
• Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

  2006influential citation
• Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK

  2006cites this paper
• Emerging Respiratory Viruses: Challenges and Vaccine Strategies

  2006cites this paper
• The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy

  2006cites this paper
• Extremely Low Exposure of a Community to Severe Acute Respiratory Syndrome Coronavirus: False Seropositivity due to Use of Bacterially Derived Antigens

  2006cites this paper
• Use of Bacterially Derived Antigens Coronavirus: False Seropositivity due to to Severe Acute Respiratory Syndrome Extremely Low Exposure of a Community

  2006cites this paper
• Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine

  2006cites this paper
• Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

  2005cites this paper
• Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus

  2005cites this paper
• SARS vaccine: progress and challenge.

  2005cites this paper
• Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies

  2005cites this paper